$Rig's Platinum Penny Alerts

[RIGATONI]

$8.82...


More tidbits...

PRTG is the company that spun out Biohaven and were bought out by Pfizer last week at $144.00 a share.

Pfizer Buys Biohaven In A $12 Billion Deal That 'Couldn't Have Come At A Better Time'

https://finance.yahoo.com/m/a73df6be-b246-3daa-b611-e7e1855c3352/pfizer-buys-biohaven-in-a-12.html

It was originally founded by the CEO of WUHN and his brothers. It was a penny stock, a pink sheet stock and both PRTG and BHVN were added to the big board.
The stock had over $450,000.00 of dollar volume on Friday and closed up and a horrible market. These Biotechs have a mind of their own and are driven by approvals along with different Phases of their drug development. They can perform well in any market. PRTG recently had a price target of $32.00. You can see that below.


About us - Portage BioTech, LLC.

https://www.portagebiotech.com/


Important to take note of this previous placement at $23.00 a share:

Portage Biotech Inc. Announces Pricing of Public Offering of 1,000,000 Ordinary Shares

Westport, Connecticut--(Newsfile Corp. - June 24, 2021) - Portage Biotech Inc. (NASDAQ: PRTG) ("Portage" or the "Company") a clinical-stage immuno-oncology company focused on the development of therapies and treatments targeting cancer treatment resistance, today announced that it has priced its previously announced underwritten public offering of 1,000,000 ordinary shares. The public offering price of each ordinary share is $23.00.



Major/Institutional holders..


Portage Biotech Inc. (PRTG) Stock Major Holders - Yahoo Finance

Yahoo Finance https://finance.yahoo.com/quote/PRTG/holders?p=PRTG


HC Wainwright & Co. Initiates Coverage On Portage Biotech with Buy Rating, Announces Price Target of $32 |Benzinga]
https://www.benzinga.com/news/22/03/26013754/hc-wainwright-co-initiates-coverage-on-portage-biotech-with-buy-rating-announces-price-target-of-32

Mar 2022 HC Wainwright & Co. Initiates Coverage On Buy
Sep 2021 Oppenheimer Initiates Coverage On Outperform
Sep 2021 B. Riley Securities Initiates Coverage On Buy

Here is one of Jeff's brothers Terrence and the history with PRTG.You will recognize some other names in there like Dr Bailey who had numerous interviews with WUHN and CEO Jeff Robinson.Search Jim Mellon and see who he is.


(4) Terence Robinson | LinkedIn

For those of you who do not have LinkedIn, here is the profile text below.

I am awaiting more details from the wuhn recent press to see how things pan out. I have not changed my strong personal beliefs that whatever Jeff is doing with wuhn, is in shareholders best interest. I am long until there's a reason not to be. The winning pedigree and performance with other public companies they have been involved with, is very apparent.

Look at the dividend PRTG paid to shareholders below.

Co-Founder
Co-Founder
Portage Biotech Inc
Portage Biotech Inc
Jun 2013 - Present · 9 yrs
Jun 2013 - Present · 9 yrs
Connecticut, United States
Connecticut, United States

Co-founded Portage Biotech in July/2013.Portage(PRTG/NASDAQ) became public as the result of a merger between Bontan Corporation a public entity and Portage, a London/England-based private entity. The controlling shareholders of Portage are Dr.Greg Bailey ( co-founder of Medivation Inc-since taken over by Pfizer for $14 B ) and Jim Mellon, a London-based investor and financier. Portage invested an initial $3 M into a Yale University-based biotech company called Biohaven. Biohaven Pharmaceutical (BHVN) IPO'd in May/2017 on the NYSE and has a current market cap of $8 Billion( $122/share). Portage paid a stock dividend in Biohaven shares (01/18) to its shareholders totaling 6 million shares ( today's value >$730 M ). Portage is now focused on new drug development for cancer treatments and is listed on NASDAQ under the symbol PRTG

Jim Mellon...

Jim Mellon - Wikipedia

https://en.wikipedia.org/wiki/Jim_Mellon

He also holds non-executive directorships at Condor Gold PLC, Bradda Head Limited (formerly Life Science Developments) and Portage Biotech Inc.

Juvenescence, a biotech company, was founded by Mellon and four others, Greg Bailey,